| Inhibition of dendritic spine morphogenesis and synaptic transmission by activity-inducible protein Homer1a C Sala, K Futai, K Yamamoto, PF Worley, Y Hayashi, M Sheng Journal of Neuroscience 23 (15), 6327-6337, 2003 | 292 | 2003 |
| Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial M Tahara, T Oeda, K Okada, T Kiriyama, K Ochi, H Maruyama, H Fukaura, ... The Lancet Neurology 19 (4), 298-306, 2020 | 262 | 2020 |
| Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial H Sawada, T Oeda, S Kuno, M Nomoto, K Yamamoto, M Yamamoto, ... PloS one 5 (12), e15298, 2010 | 172 | 2010 |
| Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease H Sawada, T Oeda, K Yamamoto, N Kitagawa, E Mizuta, R Hosokawa, ... European Journal of Neurology 16 (2), 174-182, 2009 | 96 | 2009 |
| Suppression of a neocortical potassium channel activity by intracellular amyloid-β and its rescue with Homer1a K Yamamoto, Y Ueta, L Wang, R Yamamoto, N Inoue, K Inokuchi, A Aiba, ... Journal of Neuroscience 31 (31), 11100-11109, 2011 | 78 | 2011 |
| Essential roles of Homer‐1a in homeostatic regulation of pyramidal cell excitability: a possible link to clinical benefits of electroconvulsive shock Y Sakagami, K Yamamoto, S Sugiura, K Inokuchi, T Hayashi, N Kato European Journal of Neuroscience 21 (12), 3229-3239, 2005 | 65 | 2005 |
| Baseline C-reactive protein levels and life prognosis in Parkinson disease H Sawada, T Oeda, A Umemura, S Tomita, M Kohsaka, K Park, ... PloS one 10 (7), e0134118, 2015 | 54 | 2015 |
| Baseline plasma C-reactive protein concentrations and motor prognosis in Parkinson disease A Umemura, T Oeda, K Yamamoto, S Tomita, M Kohsaka, K Park, ... PloS one 10 (8), e0136722, 2015 | 52 | 2015 |
| Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study H Sawada, T Oeda, K Yamamoto, A Umemura, S Tomita, R Hayashi, ... BMC neurology 13, 1-8, 2013 | 50 | 2013 |
| Homer 1a enhances spike‐induced calcium influx via L‐type calcium channels in neocortex pyramidal cells K Yamamoto, Y Sakagami, S Sugiura, K Inokuchi, S Shimohama, N Kato European Journal of Neuroscience 22 (6), 1338-1348, 2005 | 48 | 2005 |
| An IP3-assisted form of Ca2+-induced Ca2+ release in neocortical neurons K Yamamoto, K Hashimoto, Y Isomura, S Shimohama, N Kato Neuroreport 11 (3), 535-539, 2000 | 42 | 2000 |
| Video-fluoroscopic swallowing study scale for predicting aspiration pneumonia in Parkinson’s disease S Tomita, T Oeda, A Umemura, M Kohsaka, K Park, K Yamamoto, ... PloS one 13 (6), e0197608, 2018 | 40 | 2018 |
| A distinct form of calcium release down-regulates membrane excitability in neocortical pyramidal cells K Yamamoto, K Hashimoto, M Nakano, S Shimohama, N Kato Neuroscience 109 (4), 665-676, 2002 | 37 | 2002 |
| Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson’s disease: case–control study H Sawada, T Oeda, A Umemura, S Tomita, R Hayashi, M Kohsaka, ... PLoS One 9 (1), e85886, 2014 | 35 | 2014 |
| Early use of donepezil against psychosis and cognitive decline in Parkinson’s disease: a randomised controlled trial for 2 years H Sawada, T Oeda, M Kohsaka, A Umemura, S Tomita, K Park, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (12), 1332-1340, 2018 | 34 | 2018 |
| Diagnostic Accuracy of Apparent Diffusion Coefficient and 123I-Metaiodobenzylguanidine for Differentiation of Multiple System Atrophy and Parkinson’s Disease A Umemura, T Oeda, R Hayashi, S Tomita, M Kohsaka, K Yamamoto, ... PLoS One 8 (4), e61066, 2013 | 34 | 2013 |
| Distinct temporal profiles of activity‐dependent calcium increase in pyramidal neurons of the rat visual cortex N Kato, T Tanaka, K Yamamoto, Y Isomura The Journal of physiology 519 (2), 467-479, 1999 | 30 | 1999 |
| Impact of aspiration pneumonia on the clinical course of progressive supranuclear palsy: a retrospective cohort study S Tomita, T Oeda, A Umemura, M Kohsaka, K Park, K Yamamoto, ... PLoS One 10 (8), e0135823, 2015 | 23 | 2015 |
| Emergence of a functional coupling between inositol-1, 4, 5-trisphosphate receptors and calcium channels in developing neocortical neurons K Yamamoto, M Nakano, K Hashimoto, S Shimohama, N Kato Neuroscience 109 (4), 677-685, 2002 | 19 | 2002 |
| High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson’s disease T Oeda, M Masaki, K Yamamoto, E Mizuta, N Kitagawa, T Isono, ... Journal of neural transmission 116, 171-178, 2009 | 15 | 2009 |
Hideyuki SAWADA, MD, PhD.Medical Director, Utano National Hospital, Kyoto, JapanVerified email at nifty.com
